Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-04

FDA Approved: MIRABEGRON — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals NY LLC's generic Mirabegron for the treatment of overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)

Snippet

ORIG AP for MIRABEGRON (MIRABEGRON)